Mark Henning Anderson
When Mark Henning Anderson was diagnosed with Leukemia in 2013 and had failed to respond to a couple standard treatments, he decided it was time to try a clinical trial treatment. Under the care of the Director of Drug Development and medical oncologist/hematologist Manish R. Patel, MD, Mark began to respond well to a treatment that later went on to become FDA-approved.
Mark says, “Without Clinical Trials, I wouldn’t be here today, to be perfectly candid.”
Clinical trials are crucial to advancing cancer treatments, providing better, safer, and more effective options for patients in the future. FCS offers clinical trials at 37 of its locations.